Navigating NAFLD/NASH clinical trials through the pandemic Dr. Stephen Harrison discusses several ways the pandemic is affecting planning and execution of clinical trials and our panelists discuss implications for investors, C-suite executives and forecasters in our first episode, COVID CHAOS: Navigating NAFLD/NASH clinical trials through the pandemic. Browse Our NASH and COVID-19 Coverage https://surfingnash.com/covid-19/